Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1955-1965

  Kiss, Judit ^a   Mollenhauer, Martin ^a   Walmsley, Sarah R ^b   Kirchberg, Johanna ^a   Radhakrishnan, Praveen ^a   Niemietz, Thomas ^a   Dudda, Johanna ^a   Steinert, Gunnar ^a   Whyte, Moira K B ^b   Carmeliet, Peter ^c,d   Mazzone, Massimiliano ^c,d   Weitz, Jürgen ^a   Schneider, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYLHYDROXYLASE DOMAIN 1; PROLYLHYDROXYLASE DOMAIN 2; PROLYLHYDROXYLASE DOMAIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LETHALITY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SEPSIS; SURVIVAL TIME;

ANIMALS; BLOTTING, WESTERN; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROCOLLAGEN-PROLINE DIOXYGENASE; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84864823120     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103471     Document Type: Article

References (58)

1. Russell, J. A. 2006. Management of sepsis. N. Engl. J. Med. 355: 1699-1713. (Pubitemid 44583960)
2. Brown, M. A., and W. K. Jones. 2004. NF-kappaB action in sepsis: the innate immune system and the heart. Front. Biosci. 9: 1201-1217. (Pubitemid 39060836)
3. Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364: 656-665.
4. Imtiyaz, H. Z., E. P. Williams, M. M. Hickey, S. A. Patel, A. C. Durham, L. J. Yuan, R. Hammond, P. A. Gimotty, B. Keith, and M. C. Simon. 2010. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest. 120: 2699-2714.
5. Nizet, V., and R. S. Johnson. 2009. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9: 609-617.
6. Peyssonnaux, C., P. Cejudo-Martin, A. Doedens, A. S. Zinkernagel, R. S. Johnson, and V. Nizet. 2007. Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J. Immunol. 178: 7516-7519. (Pubitemid 46898018)
7. Frede, S., C. Stockmann, P. Freitag, and J. Fandrey. 2006. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem. J. 396: 517-527. (Pubitemid 44228166)
8. Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E. A. Theodorakis, R. L. Gallo, N. Hurtado-Ziola, V. Nizet, and R. S. Johnson. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115: 1806-1815. (Pubitemid 40979719)
9. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Förster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657. (Pubitemid 36331777)
10. Kaelin, W. G., Jr., and P. J. Ratcliffe. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30: 393-402.
11. Appelhoff, R. J., Y. M. Tian, R. R. Raval, H. Turley, A. L. Harris, C. W. Pugh, P. J. Ratcliffe, and J. M. Gleadle. 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279: 38458-38465. (Pubitemid 39295997)
12. Aragonés, J., M. Schneider, K. Van Geyte, P. Fraisl, T. Dresselaers, M. Mazzone, R. Dirkx, S. Zacchigna, H. Lemieux, N. H. Jeoung, et al. 2008. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40: 170-180. (Pubitemid 351171394)
13. Schneider, M., K. Van Geyte, P. Fraisl, J. Kiss, J. Aragones, M. Mazzone, H. Mairbaurl, K. Debock, N. H. Jeoung, M. Mollenhauer, et al. 2010. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology 138: 1143-1154.
14. Tambuwala, M. M., E. P. Cummins, C. R. Lenihan, J. Kiss, M. Stauch, C. C. Scholz, P. Fraisl, F. Lasitschka, M. Mollenhauer, S. P. Saunders, et al. 2010. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139: 2093-2101.
15. Takeda, K., V. C. Ho, H. Takeda, L. J. Duan, A. Nagy, and G. H. Fong. 2006. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26: 8336-8346. (Pubitemid 44748568)
16. Minamishima, Y. A., J. Moslehi, N. Bardeesy, D. Cullen, R. T. Bronson, and W. G. Kaelin, Jr. 2008. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111: 3236-3244.
17. Mazzone, M., D. Dettori, R. Leite de Oliveira, S. Loges, T. Schmidt, B. Jonckx, Y. M. Tian, A. A. Lanahan, P. Pollard, C. Ruiz de Almodovar, et al. 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
18. Bishop, T., D. Gallagher, A. Pascual, C. A. Lygate, J. P. de Bono, L. G. Nicholls, P. Ortega-Saenz, H. Oster, B. Wijeyekoon, A. I. Sutherland, et al. 2008. Abnormal sympathoadrenal development and systemic hypotension in PHD3-/-mice. Mol. Cell. Biol. 28: 3386-3400. (Pubitemid 351657101)
19. Minamishima, Y. A., J. Moslehi, R. F. Padera, R. T. Bronson, R. Liao, and W. G. Kaelin, Jr. 2009. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol. Cell. Biol. 29: 5729-5741.
20. Takeda, Y., S. Costa, E. Delamarre, C. Roncal, R. Leite de Oliveira, M. L. Squadrito, V. Finisguerra, S. Deschoemaeker, F. Bruyère, M. Wenes, et al. 2011. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479: 122-126.
21. Walmsley, S. R., E. R. Chilvers, A. A. Thompson, K. Vaughan, H. M. Marriott, L. C. Parker, G. Shaw, S. Parmar, M. Schneider, I. Sabroe, et al. 2011. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest. 121: 1053-1063.
22. van Schaik, S. M., and A. K. Abbas. 2007. Role of T cells in a murine model of Escherichia coli sepsis. Eur. J. Immunol. 37: 3101-3110. (Pubitemid 350131289)
23. Navarro-Xavier, R. A., J. Newson, V. L. Silveira, S. N. Farrow, D. W. Gilroy, and J. Bystrom. 2010. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184: 1516-1525.
24. Vujić Spasić, M., J. Kiss, T. Herrmann, B. Galy, S. Martinache, J. Stolte, H. J. Gröne, W. Stremmel, M. W. Hentze, and M. U. Muckenthaler. 2008. Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab. 7: 173-178. (Pubitemid 351168556)
25. Brealey, D., S. Karyampudi, T. S. Jacques, M. Novelli, R. Stidwill, V. Taylor, R. T. Smolenski, and M. Singer. 2004. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286: R491-R497. (Pubitemid 38252613)
26. Acosta-Iborra, B., A. Elorza, I. M. Olazabal, N. B. Martín- Cofreces, S. Martin-Puig, M. Miró, M. J. Calzada, J. Aragonés, F. Sánchez-Madrid, and M. O. Landázuri. 2009. Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J. Immunol. 182: 3155-3164.
27. van Rooijen, N., and E. van Kesteren-Hendrikx. 2002. Clodronate liposomes: perspectives in research and therapeutics. J. Liposome Res. 12: 81-94.
28. Paine, R., III, S. B. Morris, H. Jin, C. E. Baleeiro, and S. E.Wilcoxen. 2002. ICAM-1 facilitates alveolar macrophage phagocytic activity through effects on migration over the AEC surface. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L180-L187. (Pubitemid 34764555)
29. Hatada, E. N., D. Krappmann, and C. Scheidereit. 2000. NF-kappaB and the innate immune response. Curr. Opin. Immunol. 12: 52-58.
30. Henson, P. M., D. L. Bratton, and V. A. Fadok. 2001. Apoptotic cell removal. Curr. Biol. 11: R795-R805. (Pubitemid 32931008)
31. Takashiba, S., T. E. Van Dyke, S. Amar, Y. Murayama, A. W. Soskolne, and L. Shapira. 1999. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect. Immun. 67: 5573-5578. (Pubitemid 29508072)
32. Zinkernagel, A. S., R. S. Johnson, and V. Nizet. 2007. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. 85: 1339-1346. (Pubitemid 350234101)
33. Barnes, P. J., and M. Karin. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071. (Pubitemid 27163860)
34. Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A. S. Zinkernagel, V. Nizet, R. S. Johnson, G. G. Haddad, and M. Karin. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811. (Pubitemid 351793778)
35. Wykoff, C. C., N. J. Beasley, P. H. Watson, K. J. Turner, J. Pastorek, A. Sibtain, G. D.Wilson, H. Turley, K. L. Talks, P. H. Maxwell, et al. 2000. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60: 7075-7083. (Pubitemid 32059187)
36. Gale, D. P., and P. H. Maxwell. 2010. The role of HIF in immunity. Int. J. Biochem. Cell Biol. 42: 486-494.
37. Burke, B., N. Tang, K. P. Corke, D. Tazzyman, K. Ameri, M. Wells, and C. E. Lewis. 2002. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol. 196: 204-212. (Pubitemid 34110902)
38. Murdoch, C., M. Muthana, and C. E. Lewis. 2005. Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175: 6257-6263. (Pubitemid 41598863)
39. Takeda, N., E. L. O'Dea, A. Doedens, J. W. Kim, A. Weidemann, C. Stockmann, M. Asagiri, M. C. Simon, A. Hoffmann, and R. S. Johnson. 2010. Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24: 491-501.
40. Imtiyaz, H. Z., and M. C. Simon. 2010. Hypoxia-inducible factors as essential regulators of inflammation. Curr. Top. Microbiol. Immunol. 345: 105-120.
41. Cummins, E. P., E. Berra, K. M. Comerford, A. Ginouves, K. T. Fitzgerald, F. Seeballuck, C. Godson, J. E. Nielsen, P. Moynagh, J. Pouyssegur, and C. T. Taylor. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. USA 103: 18154-18159. (Pubitemid 44871628)
42. Silverman, N., and T. Maniatis. 2001. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15: 2321-2342. (Pubitemid 32899738)
43. Xue, J., X. Li, S. Jiao, Y. Wei, G. Wu, and J. Fang. 2010. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology 138: 606-615.
44. Fang, H. Y., R. Hughes, C. Murdoch, S. B. Coffelt, S. K. Biswas, A. L. Harris, R. S. Johnson, H. Z. Imityaz, M. C. Simon, E. Fredlund, et al. 2009. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114: 844-859.
45. Greten, F. R., M. C. Arkan, J. Bollrath, L. C. Hsu, J. Goode, C. Miething, S. I. Göktuna, M. Neuenhahn, J. Fierer, S. Paxian, et al. 2007. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130: 918-931. (Pubitemid 47332565)
46. Fong, C. H., M. Bebien, A. Didierlaurent, R. Nebauer, T. Hussell, D. Broide, M. Karin, and T. Lawrence. 2008. An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J. Exp. Med. 205: 1269-1276. (Pubitemid 351831484)
47. Winning, S., F. Splettstoesser, J. Fandrey, and S. Frede. 2010. Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B. J. Immunol. 185: 1786-1793.
48. Morote-Garcia, J. C., P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig. 2008. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580.
49. Rosenberger, P., J. M. Schwab, V. Mirakaj, E. Masekowsky, A. Mager, J. C. Morote-Garcia, K. Unertl, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10: 195-202.
50. Eltzschig, H. K., and T. Eckle. 2011. Ischemia and reperfusion - from mechanism to translation. Nat. Med. 17: 1391-1401.
51. Holgate, S. T. 2012. Innate and adaptive immune responses in asthma. Nat. Med. 18: 673-683.
52. Brusselle, G. G., G. F. Joos, and K. R. Bracke. 2011. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378: 1015-1026.
53. Chen, E. S., D. R. Moller; Medscape. 2011. Sarcoidosis - scientific progress and clinical challenges. Nat Rev Rheumatol 7: 457-467.
54. Bernhardt, W. M., M. S. Wiesener, P. Scigalla, J. Chou, R. E. Schmieder, V. Günzler, and K. U. Eckardt. 2010. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J. Am. Soc. Nephrol. 21: 2151-2156.
55. Cummins, E. P., F. Seeballuck, S. J. Keely, N. E. Mangan, J. J. Callanan, P. G. Fallon, and C. T. Taylor. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165.
56. Tanaka, T., and M. Nangaku. 2009. Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD. J. Pharmacol. Sci. 109: 24-31.
57. Boomer, J. S., K. To, K. C. Chang, O. Takasu, D. F. Osborne, A. H. Walton, T. L. Bricker, S. D. Jarman, II, D. Kreisel, A. S. Krupnick, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594-2605.
58. Inoue, S., J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, and R. S. Hotchkiss. 2010. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184: 1401-1409.